|
Match
|
Document |
Document Title |
|
|
6841173 |
Compositions and methods directed towards sore muscles and joints
Chemical formulations and methods for reducing muscle and joint soreness are disclosed. A representative chemical formulation includes compounds such as a selenium-compound, chondroitin sulfate,...
|
|
|
6838448 |
Corneal storage fluid comprised of hyaluronic acid
A solution for storing corneal tissue, especially at a temperature of 2 to 8° C., which comprises hyaluronic acid having an average molecular weight of less than 6,000,000 Da (preferably of from ...
|
|
|
6838096 |
Black soybean polysaccharides
A nutraceutical composition containing 0.01-99% by weight polysaccharides enriched from an extract of beans of Glycine max (L.) Merr. Also disclosed are a method of enriching polysaccharides from...
|
|
|
6833359 |
Method for treating soil for the control of soil borne plant pathogens
A method for reducing bacterial and fungal soil pathogens which comprises applying to a soil a chemically effective amount of a lignosulfonate, the amount preferably being between 0.05% and about...
|
|
|
6833362 |
Method and composition for the accelerated in vivo removal of ethanol
A composition for accelerating the disposal of ethanol from bodily fluid. Certain additives can accelerate the metabolic oxidation of ethanol, and others in addition act as catalysts or...
|
|
|
6833363 |
N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation
The present invention is directed to novel sulphated compounds of hyaluronic acid and derivatives thereof, optionally salified, wherein the glucosamines are partially N-sulphated and partially or...
|
|
|
6828309 |
Use of pentosan polysulfate to treat certain conditions of the prostate
The invention relates to the field of pharmacology. More particularly, the invention relates to the treatment of prostate conditions, such as BPH. The invention provides new therapeutic...
|
|
|
6828310 |
Compositions including reduced malto-oligosaccharide preserving agents, and methods for preserving a material
Disclosed is a composition that includes a material that is susceptible to degradation and a preserving agent in an amount effective to preserve the material comprising one or more reduced...
|
|
|
6828308 |
Compositions and methods for the treatment or prevention of inflammation
The present invention relates to compounds containing as active ingredients hyaluronic acid and polyvinylpyrrolidone, for the treatment of inflammatory, ulcerative and painful conditions of moist...
|
|
|
6828307 |
Low molecular weight sulphated polysaccharide to obtain a medicine with antithrombotic activity
The invention concerns the use of a sulphated polysaccharide capable of being obtained by radical depolymerization of a raw fucan derived from Pheophyceae, said polysaccharide having a molar mass...
|
|
|
6825179 |
Active ingredient combinations or adducts of cyclodextrins and quinones
Active ingredient combinations of cyclodextrins and at least one quinone and/or at least one hydroquinone for use in cosmetic or dermatological formulations.
|
|
|
6825178 |
Methods and products for treating pseudomonas infection
Methods and products for upregulating cystic fibrosis transmembrane conductance regulators are provided, including methods and products for the treatment of P. aeruginosa infection. The products...
|
|
|
6821959 |
Antibiotic-natural polysaccharide polymer adducts
Antibiotic-natural polysaccharides polymer adducts based on non-covalent and non-ionic bonds, with an improved profile of activity compared with the corresponding antibiotic.
|
|
|
6818624 |
Therapeutic agent for a cancer and method of screening the same, and health-care auxillary food
A therapeutic agent for a cancer comprising a therapeutically effective amount of an active ingredient, wherein the therapeutic agent is used referring to an ability of acting on NK cell antigen...
|
|
|
6815435 |
Pharmaceutical compositions containing DDS compounds
A pharmaceutical composition having an ensured preservation stability, which contains a compound, wherein a polysaccharide derivative having a carboxyl group is bonded to a camptothecin derivative...
|
|
|
6812215 |
Compositions for the treatment of inflammatory joint diseases and osteoporosis
Compositions and pharmaceutical compositions are described which comprise: a component A comprising one or more flavonol glycosides, a component B comprising one or more tetrahydrofolic acid...
|
|
|
6812221 |
FGF-affinity chromatography
The present invention relates to a method and apparatus for isolating anticoagulant heparin or heparan sulfate by binding the anticoagulant heparin or anticoagulant heparan sulfate onto an affinity...
|
|
|
6809084 |
Compositions containing polysaccharides from phellinus linteus and methods for treating diabetes mellitus using same
The present invention relates to a novel use of polysaccharides (PL) from Phellinus linteus for treating diabetes mellitus, which provides medicine or food comprising polysaccharide as active...
|
|
|
6805857 |
Method of modulating factor D, factor H and CD4 cell immune response with a polystyrene sulfonate, alginate, and saline infusion solution
Anthrax bio-terrorism is a poor man's nuclear bomb with devastating effects on the freedom and economy of any nation. No nation is immune. Urgently, there is a need for life saving technology that...
|
|
|
6800298 |
Biological lubricant composition and method of applying lubricant composition
Fluid compositions and methods for lubrication of mammalian joints are disclosed, including both natural and artificial fluids. Synovial fluid acts to lubricate the bearing surfaces of bones and...
|
|
|
6797705 |
Rhamnan sulphate composition for treatment of endothelial dysfunction
The invention described is a method and composition for inducing cell surface anti-thrombotic activity in endothelial cells comprising administering to a patient a therapeutically-effective amount...
|
|
|
6790840 |
Reversibly cross-linked hydrogels
A hydrogel composition and methods of preparing and using the same are disclosed. The hydrogel composition comprises an oxidized polysaccharide, and a cross-linker having at least two functional...
|
|
|
6784209 |
Food supplement for increasing lean mass and strength
Food supplement compositions and their methods of use in increasing lean mass and/or muscle size and/or strength in individuals, particularly, athletes is described. The food supplements described...
|
|
|
6780852 |
Modified polysaccharides exhibiting altered biological recognition
The invention relates to polysaccharides, polysaccharide conjugates and complexes with altered biological properties, and methods to produce these polysaccharides, polysaccharide conjugates and...
|
|
|
6777397 |
Mixtures of fructose and lactose as a low-calorie bulk sweetener with reduced glycemic index
Mixtures of fructose and lactose are useful for reducing caloric intake and glycemic index for individuals who are overweight, glucose-impaired, diabetic, or who just consume too large a fraction...
|
|
|
RE38566 |
Therapeutic carbohydrate blends for treating and aiding premenstrual syndrome
A composition is disclosed for alleviating or managing symptoms associated with premenstrual syndrome “PMS” comprising an effective amount of an aqueous mixture of water and a rapidly dig...
|
|
|
6777398 |
Process for the preparation of chondroitin sulfates from K4 polysaccharide and obtained products
New process for the preparation of chondroitin sulfates from the bacterial origin polysaccharide named K4, by defructosilation followed by selective sulfation.
|
|
|
6776979 |
Periodontal treatment compound and method of use
An oral compound of water; glycerin; a cranberry source; methylsulfonylmethane; melaleuca alternifolia oil; hydroxyethylcellulose; and a surfactant, in proper combination for use by injecting the...
|
|
|
6774111 |
Carbohydrate system and a method for providing nutrition to a diabetic
The two carbohydrate mixture of this invention utilizes a source of fructose in combination with at least one readily digestible glucose polymer source. The addition of the fructose significantly...
|
|
|
6774180 |
Synthesis of high molecular weight non-peptidic polymer derivatives
High molecular weight derivatives of activated poly(ethylene glycol) and the like polymers are prepared in high purity by conjugating a large PEG molecule to a small PEG molecule. Most of the...
|
|
|
6774113 |
Process for preparing solubilization adjuvants from fusel oils and saccharides
Process for preparing a solubilization adjuvant, which comprises placing fusel oils in contact with one or more reducing sugars in the presence of an acid catalyst, at a temperature of between 50° ...
|
|
|
6770292 |
Pharmaceutical compositions for oral administration
A method for oral administration of an active principle includes the steps of incorporating an active principle in multilamellar vesicles having a diameter of between 0.1 and 25 μm, and a lamellar ...
|
|
|
6761912 |
Composition for increasing bone density
A composition and a method for administering an improved supplement to prevent bone density loss. The composition combines a calcium compound with inulin, and optionally magnesium, Vitamin D3,...
|
|
|
6761898 |
Combination composition in the form of nutritional supplement or pharmaceutical composition for the prevention and therapeutical treatment of degenerative or inflammatory articular disorders
The present invention relates to a composition, which contains L-carnitine or alkanoyl-L-carnitine, and a glucosaminoglycan or a constituent thereof, suitable for the prevention of articular...
|
|
|
6756364 |
Method of reducing gastrointestinal side effects associated with orlistat treatment
A pharmaceutical combination or composition containing a lipase inhibitor, preferably orlistat, and a bile acid sequestrant is useful for treating obesity.
|
|
|
6756362 |
Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
The present invention relates to the discovery that biocompatible anionic polymers can effectively inhibit fibrosis, scar formation, and surgical adhesions. The invention is predicated on the...
|
|
|
6756040 |
Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminum phosphate
The invention relates to a vaccine formulation for the prevention of Haemophilus Influenzae Type B (Hib) infections and where the antigen is adsorbed onto aluminum phosphate. The invention also...
|
|
|
6750208 |
Medicine for treating apoptosis dysfunction containing oligosaccharides
The invention concerns a medicine comprising, as active principle, an efficient quantity of at least an oligosaccharide substance capable of modulating apoptosis dysfunction which is capable of...
|
|
|
6749845 |
Modulated release particles for lung delivery
A polymeric construct is disclosed. The construct comprises a polysaccharide polymer having a selected medicament associated therewith. The medicament thus present is provided in a slow release form.
|
|
|
6747015 |
Low molecular weight polymannuronate
Disclosed is a polymannuronate composition including polymannuronate having molecular weight from about 4,000 to about 500,000 in a high purity. The composition can be used in producing nutritional...
|
|
|
6733769 |
Methods for lowering viscosity of glucomannan compositions, uses and compositions
Methods of producing low viscosity glucomannan compositions by mixing a viscosity lowering compound with glucomannan under conditions suitable to form a low viscosity glucomannan composition are...
|
|
|
6733799 |
Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
A method for reducing mammalian serum total cholesterol, LDL cholesterol, apolipoprotein B and triglyceride levels, by ingesting a stabilized rice bran derivative selected from the group consisting...
|
|
|
6730323 |
Microclysmic gel for treatment of tissue trauma and burns
A therapeutic wound gel is provided which will enhance healing of the wound and reduce swelling and increase elasticity of the skin. Humatrix is bacteriostatic protectant with no bacteriocidal...
|
|
|
6727081 |
Microorganism isolated from chinese elm (Ulmus sp.) and process for preparing exopolysaccharides by employing the microorganism
The present invention relates to a novel Enterobacter sp. strain SSYL deposited under accession number KCTC 0687BP isolated from the root bark of Chinese elm, which produces immunostimulating...
|
|
|
6722062 |
Capsular polysaccharides from enterococci
The present invention is directed to a method for purifying polysaccharides capable of inducing the production of high titers of opsonic antibodies that kill strains of enterococcal bacteria. In...
|
|
|
6723737 |
Methods, pharmaceutical and therapeutic compostions for administering adenosine
The invention discloses methods for the chronic administration of adenosine, which contrary to the acute delivery of the drug by injection or infusion, acts in desensitizing adenosine receptors...
|
|
|
6723704 |
Sphingoglycolipid
A glycosphingolipid having a sugar chain containing α-glucosamine and β-glucosamine is disclosed. Such glycosphingolipid is advantageous in that possibly being manufactured in a facile and i...
|
|
|
6713459 |
Methods for the prophylactic and therapeutic treatment of cardiac tissue damage
The invention provides a method for treating tissue damage caused by ischemia/reperfusion, microbial infection, or sepsis using (1→3)-β-D-glucans to modulate immune response mediators and their ef...
|
|
|
6713460 |
Glass-like polysaccharide useful as absorbent for liquids
A particulate absorbent, for the absorption of liquids, comprising particles selected from the group consisting of particles of glass-like polysaccharides and of particles of glass-like...
|
|
|
6710038 |
Emulsification method using propylene glycol hyaluronate
Disclosed are propylene glycol hyaluronate esters having an esterification degree of 10-90% and a limiting viscosity of 3-35 dL/g as well as skin conditioning methods, moisturizing methods and...
|